Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927106 · ClinicalTrials.gov registry record
Beat AML Core Study
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 22
- Enrollment target
NCT02927106 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 22 participants.
The verdict
NCT02927106 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential therapeutics for patients with acute myeloid leukemia (AML).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2020-07-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927106
The ClinicalTrials.gov registry entry for NCT02927106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02927106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927106 about?
NCT02927106 is a clinical study titled "Beat AML Core Study". In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential therapeutics for patients with acute myeloid leukemia (AML).
What is the current status of trial NCT02927106?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2017-02-15. Estimated completion is 2020-07-29.
Who is sponsoring clinical trial NCT02927106?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.